{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:02:19Z","timestamp":1789682539419,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI104895"],"award-info":[{"award-number":["R01AI104895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI123747"],"award-info":[{"award-number":["R21AI123747"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI135522"],"award-info":[{"award-number":["R21AI135522"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08AI114883"],"award-info":[{"award-number":["K08AI114883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,30]]},"DOI":"10.1093\/cid\/ciy825","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T23:21:03Z","timestamp":1537572063000},"page":"2045-2052","source":"Crossref","is-referenced-by-count":68,"title":["Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients"],"prefix":"10.1093","volume":"68","author":[{"given":"Morgan","family":"Hakki","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romney M","family":"Humphries","sequence":"additional","affiliation":[{"name":"Accelerate Diagnostics, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peera","family":"Hemarajata","sequence":"additional","affiliation":[{"name":"Los Angeles County Department of Public Health, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B","family":"Tallman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Oregon State University\/Oregon Health and Science University College of Pharmacy, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K","family":"Shields","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta T","family":"Mettus","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pennsylvania"},{"name":"Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James S","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"2019053001004438600_CIT0001","doi-asserted-by":"crossref","first-page":"e12762","DOI":"10.1111\/tid.12762","article-title":"Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: three major threats to hematopoietic stem cell transplant recipients","volume":"19","author":"Satlin","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"2019053001004438600_CIT0002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019053001004438600_CIT0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"2019053001004438600_CIT0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/47.3.247","article-title":"Of Pseudomonas, porins, pumps and carbapenems","volume":"47","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2019053001004438600_CIT0005","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/AAC.34.11.2142","article-title":"Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin","volume":"34","author":"R\u00e5dberg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0006","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.36.9.1847","article-title":"Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa","volume":"36","author":"Masuda","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0007","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","article-title":"Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation","volume":"52","author":"Tanimoto","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jac\/29.3.307","article-title":"Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy","volume":"29","author":"Aubert","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"2019053001004438600_CIT0009","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.31.11.1803","article-title":"Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis","volume":"31","author":"Mich\u00e9a-Hamzehpour","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019053001004438600_CIT0011","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajic.2009.02.003","article-title":"Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates","volume":"37","author":"L\u00f3pez-Dupla","year":"2009","journal-title":"Am J Infect Control"},{"key":"2019053001004438600_CIT0012","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1086\/588484","article-title":"Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy","volume":"46","author":"Wolter","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019053001004438600_CIT0013","volume-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement M100-S22","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"2019053001004438600_CIT0014","volume-title":"Performance standards for antimicrobial susceptibility testing M100-S28","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"2019053001004438600_CIT0015","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M07-11","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"2019053001004438600_CIT0016","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/cmb.2013.0084","article-title":"Assembling single-cell genomes and mini-metagenomes from chimeric MDA products","volume":"20","author":"Nurk","year":"2013","journal-title":"J Comput Biol"},{"key":"2019053001004438600_CIT0017","doi-asserted-by":"crossref","first-page":"D581","DOI":"10.1093\/nar\/gkt1099","article-title":"PATRIC, the bacterial bioinformatics database and analysis resource","volume":"42","author":"Wattam","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2019053001004438600_CIT0018","doi-asserted-by":"crossref","first-page":"D206","DOI":"10.1093\/nar\/gkt1226","article-title":"The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST)","volume":"42","author":"Overbeek","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2019053001004438600_CIT0019","doi-asserted-by":"crossref","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","article-title":"FastTree 2\u2013approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"2019053001004438600_CIT0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/JCM.06094-11","article-title":"Multilocus sequence typing of total-genome-sequenced bacteria","volume":"50","author":"Larsen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2019053001004438600_CIT0021","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019053001004438600_CIT0022","doi-asserted-by":"crossref","first-page":"ofw188","DOI":"10.1093\/ofid\/ofw188","article-title":"Multidrug resistant Pseudomonas aeruginosa causing prosthetic valve endocarditis: a genetic-based chronicle of evolving antibiotic resistance","volume":"3","author":"Domitrovic","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2019053001004438600_CIT0023","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1017\/S0950268817001832","article-title":"Pseudomonas aeruginosa blood stream infection isolates from patients with recurrent blood stream infection: Is it the same genotype","volume":"145","author":"McCARTHY","year":"2017","journal-title":"Epidemiol Infect"},{"key":"2019053001004438600_CIT0024","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2019053001004438600_CIT0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2019053001004438600_CIT0026","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1128\/AAC.01388-12","article-title":"Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones","volume":"56","author":"Cabot","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0027","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0028","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1469-0691.2011.03530.x","article-title":"Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime","volume":"17","author":"Campo Esquisabel","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2019053001004438600_CIT0029","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","article-title":"Interplay of efflux system, ampC, and OprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates","volume":"50","author":"Quale","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.50.4.1347-1351.2006","article-title":"Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa","volume":"50","author":"Hocquet","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2019053001004438600_CIT0031","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jac\/dku048","article-title":"Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries","volume":"69","author":"Castanheira","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2019053001004438600_CIT0032","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jac\/dki445","article-title":"Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli","volume":"57","author":"Kern","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2019053001004438600_CIT0033","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fmicb.2012.00408","article-title":"MexXY multidrug efflux system of Pseudomonas aeruginosa","volume":"3","author":"Morita","year":"2012","journal-title":"Front Microbiol"},{"key":"2019053001004438600_CIT0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1099\/jmm.0.000413","article-title":"Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting","volume":"66","author":"McCarthy","year":"2017","journal-title":"J Med Microbiol"},{"key":"2019053001004438600_CIT0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/JCM.01859-16","article-title":"Performance of Vitek 2 for antimicrobial susceptibility testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition breakpoints","volume":"55","author":"Bobenchik","year":"2017","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/12\/2045\/28739211\/ciy825.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T01:00:56Z","timestamp":1559178056000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/12\/2045\/5107005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,9,26]]},"published-print":{"date-parts":[[2019,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy825","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,15]]},"published":{"date-parts":[[2018,9,26]]}}}